Colonization and antifungals susceptibility patterns of Candida species isolated from hospitalized patients in ICUs and NICUs

• Published in: Journal of nephropathology Vol. 4; no. 3; pp. 77 - 84
• Main Authors: Zarei Mahmoudabadi, Ali, Rezaei-Matehkolaei, Ali, Navid, Mojgan, Torabizadeh, Mehdi, Mazdarani, Shahnam
• Format: Journal Article
• Language: English
• Published: Iran Society of Diabetic Nephropathy Prevention 01.07.2015
• Subjects: amphotericin b; candida species; fluconazole; minimum inhibitory concentration; Original; terbinafine; Amphotericin B; Fluconazole; Candida species; Terbinafine; Minimum inhibitory concentration
• ISSN: 2251-8363; 2251-8819
• DOI: 10.12860/jnp.2015.15

Several studies have shown that there are an increasing in invasive candidiasis during 2-3 last decades. Although, Candida albicans is considered as the most common candidiasis agents, other non-albicans such as C. glabrata, C. krusei, C. parapsilosis, and C. tropicalis were raised as infectious agents. Resistance to fluconazole among non-albicans species is an important problem for clinicians during therapy and prophylaxis. The aim of current study was to detect the Candida species from hospitalized neonatal and children in intensive care units (ICUs) and neonatal intensive care units (NICUs). In addition, the susceptibility of isolated agents were also evaluated against three antifungals. In the present study 298 samples including 98 blood samples, 100 urines and 100 swabs from oral cavity were inoculated on CHROMagar Candida. Initial detection was done according to the coloration colonies on CHROMagar Candida . Morphology on cornmeal agar, germ tube formation and growth at 45°C were confirmed isolates. Amphotericin B, fluconazole and terbinafine (Lamisil) were used for the susceptibility tests using microdilution method. In the present study 21% and 34% of urines and swabs from oral cavity were positive for Candida species, respectively. The most common species was C. albicans (62.5%) followed by C. tropicalis (15.6%), C. glabrata (6.3%) and Candida species (15.6%). Our study indicated that the most tested species of Candida, 70.3% were sensitive to fluconazole at the concentration of ≤8 μg/mL. Whereas 9 (14.1%) of isolates were resistant to amphotericine B at ≥8 μg/mL. This study demonstrates the importance of species identification and antifungals susceptibility testing for hospitalized patients in ICUs and NICUs wards.